Sanofi

A global integrated healthcare leader discovers, develops and distributes therapeutic solutions.

Launch date

1973

Employees

Market cap

Net debt

-

Enterprise valuation

$140.3b (Public information from Jul 2024)

Paris Île-de-France (HQ)

https://www.sanofi.com/en

https://twitter.com/sanofi https://www.facebook.com/sanofiUS https://www.linkedin.com/company/1642

Corporate Venture Fund: Sanofi Ventures

Revenues, earnings & profits over time

EUR	2020	2021	2022	2023	2024	2025	2026
Revenues	37.4b	39.2b	45.4b	46.4b	46.3b	50.0b	52.8b
% growth	(1 %)	5 %	16 %	2 %	-	8 %	6 %
EBITDA	9.8b	10.8b	13.8b	15.2b	13.6b	15.5b	16.6b
% EBITDA margin	26 %	27 %	30 %	33 %	29 %	31 %	31 %
Profit	12.3b	6.2b	6.7b	5.4b	7.1b	8.7b	9.6b
% profit margin	33 %	16 %	15 %	12 %	15 %	17 %	18 %
EV / revenue	2.9x	3.1x	2.6x	2.6x	2.6x	2.4x	2.1x
EV / EBITDA	11.0x	11.3x	8.7x	7.9x	9.0x	7.6x	6.8x
R&D budget	5.5b	5.7b	6.7b	6.7b	-	-	-
R&D % of revenue	15 %	15 %	15 %	14 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Jul 2002	N/A	N/A	IPO
Dec 2014	Evotec	$310m	Post IPO Equity
Apr 2020	Biomedical Advanced Research and Development Authority (BARDA)	$30.8m	Grant
Jul 2020	Biomedical Advanced Research and Development Authority (BARDA)	$2.0b	Grant
Oct 2023*	Carson Advisory	$229k	-
Total Funding		$2.0b

Tech stackLearn more about the technologies and tools that this company uses.

ACQUISITION by Sanofi Jan 2021

Principia BioPharma

ACQUISITION by Sanofi Aug 2020

ACQUISITION by Sanofi Jan 2018

Esperance Pharmaceuticals

ACQUISITION by Sanofi Apr 2021

ACQUISITION by Sanofi Sep 2021

ACQUISITION by Sanofi Aug 2021

Thermalin Diabetes